Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Integrin beta4 signaling promotes tumor angiogenesis.

Cancer cell | Nov 15, 2004

http://www.ncbi.nlm.nih.gov/pubmed/15542431

Mice carrying a targeted deletion of the signaling portion of the integrin beta4 subunit display drastically reduced angiogenesis in response to bFGF in the Matrigel plug assay and to hypoxia in the retinal neovascularization model. Molecular cytology indicates that alpha6beta4 signaling promotes branching of beta4+ medium- and small-size vessels into beta4- microvessels without exerting a direct effect on endothelial cell proliferation or survival. Signaling studies reveal that alpha6beta4 signaling induces endothelial cell migration and invasion by promoting nuclear translocation of P-ERK and NF-kappaB. Upon subcutaneous implantation of various cancer cells, the mutant mice develop smaller and significantly less vascularized tumors than wild-type controls. These results provide genetic evidence that alpha6beta4 signaling promotes the onset of the invasive phase of pathological angiogenesis and hence identify a novel target for antiangiogenic therapy.

Pubmed ID: 15542431 RIS Download

Mesh terms: Animals | Cell Movement | Cell Proliferation | Cell Survival | Collagen | Drug Combinations | Endothelial Cells | Gene Deletion | Humans | Integrin alpha6beta4 | Integrin beta4 | Laminin | Mice | Mice, Mutant Strains | Models, Biological | Neoplasms | Neovascularization, Pathologic | Paraffin Embedding | Proteoglycans | Retina | Signal Transduction | Tumor Cells, Cultured

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: F32 CA97886
  • Agency: NCI NIH HHS, Id: P30 CA08748
  • Agency: NCI NIH HHS, Id: R37 CA58976

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.